Effects of lipid-lowering on oxidative stress,inflammatory factor and kidney in hyperlipidemia rat models
Zi-long ZHANG,Ying-shuo HUANG,Mei-lin LIU
DOI: https://doi.org/10.16680/j.1671-3826.2018.05.17
2018-01-01
Abstract:Objective To investigate the effects of lipid-lowering on oxidative stress,inflammatory factor and kidney in hyperlipidemia rat models. Methods A total of 42 Wistar rats were randomly divided into the control group(n=13)and the experiment group(n=29). The rats in the control group were given normal feeding,the others in the experiment group were given high cholesterol diet feeding. After 6 weeks,5 rats in each group were randomly selected to detect the lipid. After the model establishment,the rest rats in the experiment group(n=24)were randomly divided into the hyperlipidemia model group(n=8),lovastatin group(n=8)and the Hypocol group(n=8). The rats in the Xuezhikang group were continuely fed with high cholesterol diet,and were given lovastatin(2. 5 mg/kg/day) and Xuezhikang(300. 0 mg/kg/day). After 12 weeks,the serum lipid,renal function,malonaldehyde( MDA) and total antioxidant capacity(T-AOC)were detected. Tumor necrosis factor-α(TNF-α)and interleukin-6(IL-6)were detected by ELISA;TNF-α and transforming growth factor-β(TGF-β)were detected by kidney Masson,PAS staining and immunohistochemistry. Results The levels of triglyceride(TG),TCHO,LDL-C,TNF-α,IL-6,Scr,BUN,UA and MDA in the hyperlipidemia model group were all higher than those of the drug intervention groups(P<0. 05);the levels of HDL-C and T-AOC in the hyperlipidemia model group were lower than those of the drug intervention groups(P<0. 05). Compared with the hyperlipidemia model group,the renal function level in the Xuezhikang group and the lovastatin group were lower(P<0. 05). The level of inflammation in the Xuezhikang group was lower than that in the lovastatin group(P<0. 05),while the antioxidant was similar to that in the lovastatin group(P>0. 05). Morphological examination revealed that renal collagen proliferation in the hyperlipidemia model group. Immunohistochemical suggested that TNF-α was the lowest expression in the control group,glomerular cell TNF-α,TGF-βand glomerular mesangial cells TGF-β were the highest positive expression in the hyperlipidemia model group,and higher in the drug intervention groups. There were no significant differences between the Xuezhikang and lovastatin groups in blood lipid level,renal function and renal pathology(P>0. 05). Conclusion Xuezhikang and lovastatin can regulate blood lipid,and through lowering TNF-α,IL-6 and MDA to elevate the level of T-AOC,exert anti-inflammatory and anti-oxidative effects,and protect the renal injury induced by abnormal blood lipid.